Angiogenin, interleukins, and growth-factor levels in serum of patients with ovarian cancer: Correlation with angiogenesis

Cancer Journal from Scientific American

Volumn 2, Issue 5, 1996, Pages 279-285

  Chopra, Vimlarani ^a,b   Dinh, Tung V ^a   Hannigan, Edward V ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Angiogenesis; Angiogenin; Growth factors; Interleukins; Ovarian cancer; Tumor progression

Indexed keywords

ANGIOGENIN; FIBROBLAST GROWTH FACTOR 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH PROMOTOR; INTERLEUKIN DERIVATIVE; PANCREATIC RIBONUCLEASE; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD; CANCER STAGING; COLLOID CARCINOMA; CYSTADENOCARCINOMA; ENDOMETRIOID CARCINOMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); OVARY TUMOR; PATHOLOGY; VASCULARIZATION;

ADENOCARCINOMA, MUCINOUS; ADULT; CARCINOMA, ENDOMETRIOID; CYSTADENOCARCINOMA, SEROUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTOR 2; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GROWTH SUBSTANCES; HUMANS; INTERLEUKINS; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; RIBONUCLEASE, PANCREATIC; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0002965441     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Malik S, Balkwill F. Epithelial ovarian cancer: a cytokine propelled disease? Br J Cancer 1991;4:617-620.
2. Watson JM, Sensintaffar JL, Berek JS, Martínez-Maza O. Constitutive production of interleukin-6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res 1990;50: 6959-6965.
3. Londei M, Clayton J, Feldman M. T cells and cytokines. In: Balkwill FR, ed. Cytokines: A Practical Approach. London: IRL Press, 1991;151-168.
4. Berek JS, Chung C, Kaldi K, Watson JM, Knox RM, Martínez-Maza O. Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am J Obstet Gynecol 1991;164:1038-1043.
5. Moradi MM, Carson LF, Weinberg JB, Haney AF, Twiggs LB, Ramakrishnan S. Serum and ascitic fluid levels of Interleukin-1, Interleukin-6 and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer 1993;72:2433-2440.
6. Motro B, Itin A, Sachs L, Keshet E. Pattern of Interleukin-6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci USA 1990;87:3092-3096.
7. Grosen EA, Yamamoto RS, Ioli G et al. Blocking factors (soluble membrane receptors) for tumor necrosis factor and lymphotoxin detected in ascites and released in short-term cultures obtained from ascites and solid tumors in women with gynecologic malignancy. Lymph Cyt Res 1992;11:347-353.
8. De Jaco P, Asselain B, Orlandi C, Fridman WH, Teillaud JL. Evaluation of circulating tumor necrosis factor-α in patients with gynecological malignancies. Int J Cancer 1991;48:375-378.
9. Klagsburn M, D'Amore PA. Regulators of angiogenesis. Annu Rev Physiol 1991;53:217-239.
10. Folkman J. Tumor angiogenesis. Adv Cancer Res 1985;43:175-203.
11. Folkman J, Klagsburn M. Angiogenic factors. Science 1987;235: 442-447.
12. Folkman J. Toward an understanding of angiogenesis: search and discovery. Perspect Biol Med 1985;29:10-36.
13. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58-61.
14. Sunderkötter C, Goebeler M, Schulze-Osthoff K, Bhardwaj R, Sorg C. Macrophage-derived angiogenesis factors. Pharm Ther 1991;51:195-216.
15. Dejana E, Bussolino F, Wang JM, Mantovani A. Cytokine regulation of endothelial cells. In: Balkwill FR, ed. Cytokines: A Practical Approach. London: IRL Press, 1991:215-227.
16. Kristensen MS, Paludan K, Larsen CG et al. Quantitative determination of IL-1α-induced IL-8 mRNA levels in cultured human keratinocytes, dermal fibroblasts, endothelial cells and monocytes. J Invest Dermatol 1991;97:506-510.
17. Detmar M, Tenorio S, Hettmannsperger U, Ruszczak Z, Orfanos CE. Cytokine regulation of proliferation and ICAM-1 expression of human dermal microvascular endothelial cells in vitro. J Invest Dermatol 1992;98:147-153.
18. BenEzra D, Hemo I, Maftzir G. In vivo angiogenic activity of interleukins. Arch Opthalmol 1990;108:573-576.
19. Cozzolino F, Torcia M, Aldinucci D et al. Interleukin-1 is an autocrine regulator of human endothelial cell growth. Proc Natl Acad Sci USA 1990;87:6487-6491.
20. Cozzolino F, Torcia M, Lucibello M et al. Interferon-α and Interleukin-2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth. J Clin Invest 1993;91:2504-2512.
21. Watson JM, Berek JS, Martínez-Maza O. Growth inhibition of ovarian cancer cells induced by antisense IL-6 oligonucleotides. Gynecol Oncol 1993;49:8-15.
22. Alderson MR, Tough TW, Ziegler SF, Grabstein KH. Interleukin-7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes. J Exp Med 1991;173:923-930.
23. Koch AE, Polverini PJ, Kunkel SL et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992;258:1798-1801.
24. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993;11:165-190.
25. Gotleib WH, Abrams JS, Watson JM, Velu TJ, Berek JS, Martínez-Maza O. Presence of interleukin-10 (IL-10) in the ascites of patients with ovarian and other abdominal cancers. Cytokine 1992;4:385-390.
26. Grosen EA, Granger GA, Gatanga M et al. Measurement of the soluble membrane receptors for tumor necrosis factor and lymphotoxin in the sera of patients with gynecologic malignancy. Gynecol Oncol 1993;50:68-77.
27. Presta M, Rusnati M, Maier JAM et al. Basic fibroblast growth factor and endothelial cells: receptor interaction, signal transduction, cellular response-dissociation of the mitogenic activity of β-FGF from its plasminogen activator inducing activator inducing capacity. In: Maragoudakis ME, Gullino P, Lelkes PI, eds. Angiogenesis in Health and Disease. 1991;227:79-89.
28. Wiseman DM, Polverini PJ, Kamp DW, Leibovich SJ. Transforming growth factor-beta (TGF-β) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun 1988;157:793-800.
29. Baiocchi G, Kavanagh JJ, Talpaz M, Wharton JT, Gutterman JU, Kurzrock R. Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malagnancies. Cancer 1991; 67:990-996.
30. Soncin F. Angiogenin supports endothelial and fibroblast cell adhesion. Proc Natl Acad Sci USA 1992;89:2232-2236.
31. Moenner M, Gusse M, Hatzi E, Badet J. The widespread expression of angiogenin in different human cells suggests a biological function not only related to angigiogenesis. Eur J Bio. 1994;226: 483-490.
32. Blaser J, Triebel S, Kopp C, Tschesche H. A highly sensitive immunoenzymometric assay for the determination of angiogenin. Eur J Clin Chem Clin Biochem 1993;31:513-516.